The Company is engaged in pharmaceutical business comprising of the manufacture and sales of active pharmaceutical ingredients (APIs), finished formulations and point-of-care (POC) medical devices. Over-the-Counter drugs (OTC) business is already being carried on through its wholly owned subsidiary, Dr. Morepen Limited. Having established itself